Health Canada Report: No OTC NSAID Label Changes Needed
This article was originally published in The Tan Sheet
Executive Summary
Canadian manufacturers of nonprescription ibuprofen products will not have to make any label changes regarding cardiovascular risks that may be associated with the non-steroidal anti-inflammatory drugs class, Health Canada states in documents released June 14